The influence of the immunostimulation by bacterial cell components derived from altered large intestinal microbiota on probiotic anti-inflammatory benefits

FEMS Immunology and Medical Microbiology

Volumn 49, Issue 3, 2007, Pages 387-390

  Matsumoto, Mitsuharu ^a,b   Hara, Kurt ^a   Benno, Yoshimi ^b  

^a Nishitama gun   (Japan)

^b RIKEN BIORESOURCE CENTER   (Japan)

Author keywords

Anti inflammation; Intestinal microbiota; J774.1 cell; Probiotics

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1ALPHA; LKM 512; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; YOGHURT;

ACUTE PHASE RESPONSE; AGED; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL CELL; BIFIDOBACTERIUM ANIMALIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG INHIBITION; FECES; FEMALE; HUMAN; IMMUNOSTIMULATION; INFLAMMATION; INTESTINE FLORA; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; VOLUNTEER;

AGED; ANIMALS; ANTI-INFLAMMATORY AGENTS; BACTERIA; CELL LINE; FECES; FEMALE; GASTROINTESTINAL TRACT; HUMANS; INTERLEUKIN-10; INTERLEUKIN-1ALPHA; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; PROBIOTICS; TUMOR NECROSIS FACTOR-ALPHA; YOGURT;

EID: 33947230248     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2007.00215.x     Document Type: Article

References (21)

1. Cummings JH, Banwell JG, Englyst HN, Coleman N, Segal I & Bersohn D (1990) The amount and composition of large bowel contents. Gastroenterology 98: A408.
2. Finegold SM, Sutter VL & Mathisen GE (1983) Normal indigenous flora. Human Intestinal Microflora in Health and Disease (Hentges DJ, ed), pp. 3-31. Academic Press, New York.
3. Hessle C, Andersson B &Wold AE (2000) Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while Gram-negative bacteria preferentially stimulate IL-10 production. Infect Immunol 68: 3581-3586.
4. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K & Akira S (1999) Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162: 3749-3752.
5. Isolauri E, Arvola T, Sutas Y, Moilanen E & Salminen S (2000) Probiotics in the management of atopic eczema. Clin Exp Allergy 30: 1604-1610.
6. Karlsson H, Hessle C & Rudin A (2002) Innate immune responses of human neonatal cells to bacteria from the normal gastrointestinal flora. Infect Immunol 70: 6688-6696.
7. Karlsson H, Larsson P, Wold AE & Rudin A (2004) Pattern of cytokine responses to gram-positive and gram-negative commensal bacteria is profoundly changed when monocytes differentiate into dendric cells. Infect Immunol 72: 2671-2678.
8. Kimoto H, Mizumachi K, Okamoto T & Kurisaki J (2004) New Lactococcus strain with immunomodulatory activity: enhancement of Th1-type immune response. Microbiol Immunol 48: 75-82.
9. Matsumoto M & Benno Y (2006) Consumption of probiotic yogurt containing Bifidobacterium animalis subsp. lactis LKM512 produces anti-inflammatory metabolites in the gut. Biosci Biotech Biochem 70: 1287-1292.
10. Matsumoto M, Tadenuma T, Nakamura K, Kume H, Imai T, Kihara R, Watanabe M & Benno Y (2000) Effect of Bifidobacterium lactis LKM 512 yoghurt on fecal microflora in middle to old aged persons. Microbial Ecol Health Dis 12: 77-80.
11. Matsumoto M, Ohishi H & Benno Y (2001) Impact of LKM512 yogurt on improvement of intestinal environment of the elderly. FEMS Immunol Med Microbiol 31: 181-186.
12. Matsumoto M, Tani H, Ono H, Ohishi H & Benno Y (2002) Adhesive property of Bifidobacterium lactis LKM512 and predominant bacteria of intestinal microflora to human intestinal mucin. Curr Microbiol 44: 212-215.
13. Matsumoto M, Ohishi H & Benno Y (2004) H1-ATPase activity in Bifidobacterium with special reference to acid tolerance. Int J Food Microbiol 93: 109-113.
14. Moore WEC & Holdman LV (1974) Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Appl Microbiol 27: 961-979.
15. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S & Medzhitov R (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241.
16. Shimada T, Cheng L, Enomoto T, Yang X, Miyoshi A & Shirakawa T (2004) Lysed Enterococcus faecalis FK-23 oral administration reveals inverse association between tuberculin responses and clinical manifestations in perennial allergic rhinitis: a pilot study. J Investig Allergol Clin Immunol 14: 187-192.
17. Stephen AM & Cummings JH (1980) The microbial contribution to human faecal mass. J Med Microbiol 13: 45-56.
18. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K & Akira S (1999) Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11: 443-451.
19. Underhill DM, Ozinsky A, Hajjar AM, Stevens A, Wilson CB, Bassetti M & Aderem A (1999) The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401: 811-815.
20. van Nuenen MH, de Ligt RA, Doornbos RP, van der Woude JC, Kuipers EJ & Venema K (2005) The influence of microbial metabolites on human intestinal epithelial cells and macrophages in vitro. FEMS Immunol Med Microbiol 45: 183-189.
21. Yang S, Sugawara S, Monodane T, Nishijima M, Adachi Y, Akashi S, Miyake K, Hase S & Takada H (2001) Micrococcus luteus teichuronic acids activate human and murine monocytic cells in a CD14- and toll-like receptor 4-dependent manner. Infect Immunol 69: 2025-2030.